Inhibition of GPR30 by estriol prevents growth stimulation of triple-negative breast cancer cells by 17β-estradiol

Overview of attention for article published in BMC Cancer, December 2014

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (79th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

Mentioned by

patent: 3 patents

wikipedia: 3 Wikipedia pages

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 38 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

TREATMENT OF ADVANCED ESTROGEN RECEPTOR POSITIVE BREAST CANCER

Application WO-2019211323-A1

World Intellectual Property Organisation (WIPO)

ESTRIOL COMPONENT FOR USE IN THE TREATMENT OF ER-POSITIVE CANCERS

Application WO-2019166430-A1

World Intellectual Property Organisation (WIPO)

MEDICINAL AMBROSIA PLANT EXTRACTS

Application WO-2017044860-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.